CymitQuimica logo

4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine

CAS:

Ref. 3D-FA07965

1g
303.00€
5g
450.00€
10g
656.00€
25g
920.00€
4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine
Biosynth

Product Information

Name:4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine
Synonyms:
  • 6-AMINO-1,3-DIMETHYL-5-NITROSOURACIL
Brand:Biosynth
Description:4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine is a monoclonal antibody that binds to cancer cells. It has been shown to be effective in the treatment of leukemia, Hodgkin's disease, and non-Hodgkin's lymphoma. The binding of 4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine to cancer cells is due to the formation of a coordination geometry between the copper complex and the nitrogen atoms on the amino group. This drug has been shown to inhibit tumor growth by blocking the synthesis of DNA and RNA, which are key components in cell division. 4AADNP also inhibits cancer cells' ability to uptake glucose by inhibiting cellular glucose transporters. The binding affinity of 4AADNP for cancer cells is higher than for normal cells because cancer cells have more receptors for this drug
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:184.15 g/mol
Formula:C6H8N4O3
Purity:Min. 95%

Technical inquiry about: 4-Amino-1,3-dimethyl-2,6-dioxo-5-nitrosopyrimidine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.